| abstract |
Use of a compound represented by the structure: ** Formula ** to treat and avoid a disorder or disease associated with a RyR that regulates the functioning of calcium channels in cells, or in the manufacture of a medicament for such treatment or prevention, in which the disorder or disease that is associated with RyR is selected from the group consisting of skeletal muscle disorders and diseases, cognitive disorders and diseases, malignant hyperthermia, diabetes, and sudden infant death. |